Medindia

X

Study Explores Use of Rapamycin and FK506 for Peripheral Nerve Repair

by Kathy Jones on  August 30, 2014 at 3:57 PM Research News   - G J E 4
Researchers are now focusing on areas such as nerve repair and use of stem cell therapy for the same.
 Study Explores Use of Rapamycin and FK506 for Peripheral Nerve Repair
Study Explores Use of Rapamycin and FK506 for Peripheral Nerve Repair
Advertisement

FK506 possesses a well-studied neuroregenerative effect, stimulating neurite extension in the presence of nerve growth factor in vitro, and enhancing nerve regeneration following nerve crush injury and isografting.

Advertisement
However, the use of FK506 to stimulate nerve regeneration is limited because of the risk of renal failure and hypertension, and its considerable cost. With long-term allografts, FK506 alone or combined with other drugs reportedly cause life-threatening infections. Like FK506, rapamycin is an immunosuppressant and FKBP-12-binding ligand, and has a neuroregenerative effect in vitro.

Rapamycin has lower nephrotoxicity, lower risk of hypertension, and less neoplastic potential than FK506. Dr. Yixia Yin and co-workers from Wuhan University of Technology in China found that the lowest rapamycin concentration (1.53 nmol/L) more significantly promoted Schwann cell migration than the highest FK506 concentration (100 μmol/L). Rapamycin promoted the secretion of nerve growth factors and upregulated growth-associated protein 43 expression in Schwann cells, but did not significantly affect Schwann cell proliferation. Therefore, rapamycin has potential application in peripheral nerve regeneration therapy. These findings have been published in the Neural Regeneration Research.



Source: Eurekalert
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All

More News on: